Autres langues Invion Limited

Actions

IVX

AU000000IVX4

Marché Fermé - Australian S.E. Autres places de cotation 08:10:12 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,005 ^AUD	-16,67%		-16,67%	0,00%

05/03	Le médicament anticancéreux d'Invion obtient des résultats positifs lors des essais précliniques	MT
27/02	Invion Limited annonce ses résultats pour le semestre clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Invion's Anti-Cancer Drug Logs Postive Preclinical Trial Results	05/03
Invion Limited Reports Earnings Results for the Half Year Ended December 31, 2023	27/02
Invion Signs Collaboration Agreement with Dr. I&B Co for HPV Treatment; Shares Up 25%	23/02
Invion Nears Clinical Trial of Cancer Photodynamic Therapy with Drug Substance Production	21/11
Invion Grants RMW Cho Group Right to Distribute Cancer Treatment Products in South Korea	26/09/23
Invion Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
Invion Launches New Interactive Investor Hub	11/04/23
Invion Limited agreed to acquire Next Generation Photodynamic Therapy of RMW Cho Group Limited.	06/04/23
Invion Limited Reports Earnings Results for the Half Year Ended December 31, 2022	22/02/23
Invion Expanding Photosoft Technology Rights to US, Canada, Hong Kong	08/02/23
Invion Limited Announces Vitro Test Results on Photosoft	26/10/22
Invion Limited Announces the Positive Screening Results from in Vitro Studies of PhotosoftTM on the Inhibition of the Dengue Virus	24/10/22
Invion Validates Efficacy of Photodynamic Drug Against Anal Cancer	15/09/22
Invion Limited Announces INV043 Effective Against Anal Cancer Squamous Cell Carcinomas in Vitro	15/09/22
Invion Limited Announces PhotosoftTM Shows Activity Against Zika Virus in Preliminary Assays	08/09/22
Invion Limited Reports Earnings Results for the Full Year Ended June 30, 2022	18/08/22
Invion : Activities Report and Appendix 4C	21/07/22
Invion : Notification regarding unquoted securities - IVX	20/06/22
Invion's Cancer Treatment Patent Application Published	09/06/22
Invion Limited Announces International Patent to Extend IP Protection for Photosoft	08/06/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Invion Limited

Actions

IVX

AU000000IVX4

Autres langues

Filtres